Michael J. Detke, Chief Medical Officer at Cortexyme, Inc. (CRTX), sold 115,711 shares at $53.43 ($6.3M) on 2021-07-06, disclosed to the SEC on 2021-07-07.
Open-market sale of $6.3M CRTX by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $53.43 | 32,313 | $1.7M | 27.6% |
| 2 | $53.43 | 32,313 | $1.7M | 27.6% |
| 3 | $53.91 | 8,260 | $445K | 7.1% |
| 4 | $53.91 | 8,260 | $445K | 7.1% |
| 5 | $55.01 | 288 | $16K | 0.3% |
| 6 | $53.24 | 3,934 |
| $209K |
| 3.4% |
| 7 | $53.24 | 3,934 | $209K | 3.4% |
| 8 | $54.37 | 1,648 | $90K | 1.4% |
| 9 | $54.37 | 1,648 | $90K | 1.4% |
| 10 | $55.38 | 4,353 | $241K | 3.9% |
| 11 | $55.38 | 4,353 | $241K | 3.9% |
| 12 | $56.27 | 6,942 | $391K | 6.2% |
| 13 | $56.27 | 6,942 | $391K | 6.2% |
| 14 | $56.99 | 523 | $30K | 0.5% |
| Total | $54.02 avg | 115,711 | $6.3M | 100% |